Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
The price of Medtronic Plc (NYSE: MDT) closed at $92.04 in the last session, down -0.72% from day before closing price of $92.71. In other words, the price has decreased by -$0.72 from its previous closing price. On the day, 4.76 million shares were traded. MDT stock price reached its highest trading level at $93.05 during the session, while it also had its lowest trading level at $91.92.
Ratios:
We take a closer look at MDT’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 13.15 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 22.24. For the most recent quarter (mrq), Quick Ratio is recorded 1.42 and its Current Ratio is at 1.85. In the meantime, Its Debt-to-Equity ratio is 0.62 whereas as Long-Term Debt/Eq ratio is at 0.55.
On June 16, 2025, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $110. Citigroup Upgraded its Neutral to Buy on March 04, 2025, whereas the target price for the stock was revised from $92 to $107.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 22 ’25 when Jellison William R bought 2,500 shares for $92.73 per share. The transaction valued at 231,825 led to the insider holds 2,500 shares of the business.
Jellison William R bought 2,500 shares of MDT for $230,925 on Aug 25 ’25. The Director now owns 5,000 shares after completing the transaction at $92.37 per share. On Jun 06 ’25, another insider, Salmon Sean, who serves as the Officer of the company, bought 18,378 shares for $86.81 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MDT now has a Market Capitalization of 117927174144 and an Enterprise Value of 138801381376. As of this moment, Medtronic’s Price-to-Earnings (P/E) ratio for their current fiscal year is 25.40, and their Forward P/E ratio for the next fiscal year is 15.18. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 4.32. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.45 while its Price-to-Book (P/B) ratio in mrq is 2.46. Its current Enterprise Value per Revenue stands at 4.059 whereas that against EBITDA is 14.818.
Stock Price History:
The Beta on a monthly basis for MDT is 0.79, which has changed by 0.036486506 over the last 52 weeks, in comparison to a change of 0.14460516 over the same period for the S&P500. Over the past 52 weeks, MDT has reached a high of $96.25, while it has fallen to a 52-week low of $79.29. The 50-Day Moving Average of the stock is 2.49%, while the 200-Day Moving Average is calculated to be 5.42%.
Shares Statistics:
According to the various share statistics, MDT traded on average about 7.90M shares per day over the past 3-months and 8673370 shares per day over the past 10 days. A total of 1.28B shares are outstanding, with a floating share count of 1.28B. Insiders hold about 0.13% of the company’s shares, while institutions hold 86.42% stake in the company. Shares short for MDT as of 1753920000 were 11596349 with a Short Ratio of 1.47, compared to 1751241600 on 12059795. Therefore, it implies a Short% of Shares Outstanding of 11596349 and a Short% of Float of 0.91.
Dividends & Splits
The forward annual dividend rate for MDT is 2.81, which was 2.81 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.030309567The stock’s 5-year Average Dividend Yield is 2.82. The current Payout Ratio is 77.47% for MDT, which recently paid a dividend on 2025-06-27 with an ex-dividend date of 2025-09-26. Stock splits for the company last occurred on 1999-09-27 when the company split stock in a 2:1 ratio.
Earnings Estimates
The market rating for Medtronic Plc (MDT) is a result of the insights provided by 25.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is $1.35, with high estimates of $1.38 and low estimates of $1.32.
Analysts are recommending an EPS of between $5.69 and $5.58 for the fiscal current year, implying an average EPS of $5.63. EPS for the following year is $6.06, with 32.0 analysts recommending between $6.23 and $5.83.
Revenue Estimates
According to 25 analysts, the current quarter’s revenue is expected to be $8.85B. It ranges from a high estimate of $8.9B to a low estimate of $8.75B. As of the current estimate, Medtronic Plc’s year-ago sales were $8.4BFor the next quarter, 25 analysts are estimating revenue of $8.84B. There is a high estimate of $8.93B for the next quarter, whereas the lowest estimate is $8.71B.
A total of 31 analysts have provided revenue estimates for MDT’s current fiscal year. The highest revenue estimate was $36.09B, while the lowest revenue estimate was $35.09B, resulting in an average revenue estimate of $35.74B. In the same quarter a year ago, actual revenue was $33.54BBased on 31 analysts’ estimates, the company’s revenue will be $37.64B in the next fiscal year. The high estimate is $38.42B and the low estimate is $36.8B.
